Trademark: 79240249
Word
IKSUDA THERAPEUTICS
Status
Registered
Status Code
700
Status Date
Tuesday, June 11, 2019
Serial Number
79240249
Registration Number
5772193
Registration Date
Tuesday, June 11, 2019
Mark Type
4000
Filing Date
Thursday, May 17, 2018
Published for Opposition
Tuesday, March 26, 2019

Trademark Owner History
IKSUDA THERAPEUTICS LIMITED - Original Registrant

Classifications
1 Chemical products for use in industry and science; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; antibody reagents for scientific purposes; in-vivo diagnostic reagents for scientific or research use; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for industrial use; cell culture media for use in scientific research; active chemical ingredients for use in the manufacture of anti-cancer drugs
5 Pharmaceuticals for the treatment of cancer; pharmaceuticals and medical preparations for the treatment of inflammatory diseases; vaccines for the treatment of cancer; vaccines for the treatment of gene and cell therapy; vaccines for the treatment of inflammatory diseases; pharmaceutical and medical preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the prevention and treatment of cancer; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of inflammatory diseases; hormones and analogues for medical purposes; biopharmaceutical and pharmaceutical gene and cell therapy products, namely, therapeutic pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
16 Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine
42 Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; medical and pharmaceutical research services; research and development of vaccines and medicines; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; scientific research; pharmaceutical research; biological research; biotechnology testing services namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; medical research services in the field of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines and gene therapy; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; information, advisory and consultancy services relating to the aforesaid
"THERAPEUTICS"
The wording "IKSUDA" has no meaning in a foreign language.

Trademark Events
Feb 12, 2021
Change Of Name/Address Rec'd From Ib
Jan 22, 2021
New Representative At Ib Received
Oct 25, 2019
Final Decision Transaction Processed By Ib
Sep 21, 2019
Final Disposition Notice Sent To Ib
Sep 21, 2019
Final Disposition Processed
Sep 11, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jun 11, 2019
Registered-Principal Register
Mar 26, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 26, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 26, 2019
Published For Opposition
Mar 23, 2019
Notification Processed By Ib
Mar 6, 2019
Notification Of Possible Opposition Sent To Ib
Mar 6, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 6, 2019
Notice Of Publication
Feb 15, 2019
Approved For Pub - Principal Register
Feb 7, 2019
Teas/Email Correspondence Entered
Feb 7, 2019
Correspondence Received In Law Office
Feb 4, 2019
Assigned To Lie
Feb 1, 2019
Change Of Name/Address Rec'd From Ib
Jan 31, 2019
Teas Response To Office Action Received
Oct 13, 2018
Refusal Processed By Ib
Sep 21, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Sep 21, 2018
Refusal Processed By Mpu
Sep 18, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Sep 18, 2018
Application Filing Receipt Mailed
Sep 17, 2018
Non-Final Action Written
Sep 13, 2018
Assigned To Examiner
Sep 13, 2018
Assigned To Examiner
Sep 13, 2018
New Application Office Supplied Data Entered In Tram
Sep 6, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24